Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article September 1 2025
Inferior Survival in Double Refractory Large B-cell Lymphoma Eligible for third-line CD19 CAR T-cell Therapy
Research Article August 25 2025
Application of the International Working Group MDS Molecular Taxonomy Classes to a Single Institution Cohort
Research Article August 25 2025
Final Safety and Efficacy Results from a Phase 1/2 Study of Tagraxofusp, a CD123-Targeted Therapy, for Myelofibrosis
Research Article August 25 2025
Predicting Secondary Myeloid Neoplasms in Acquired Aplastic Anemia Using Machine Learning Models
Research Article August 25 2025
Analyses of transplantation outcomes for adult patients with mixed-phenotype acute leukemia
Research Article August 19 2025
Second Malignancies among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib
Research Article August 19 2025
Posttransplant Rituximab Exposure and Risk of PTLD in Solid Organ Transplant Recipients with EBV DNAemia
Research Article August 19 2025
Azanucleoside treatment leads to B cell precursor acute lymphoblastic leukemia (BCP ALL)
Research Article August 5 2025
Disparities in Real-World Treatment Patterns of Hypomethylating Agents Among Patients with Myelodysplastic Syndromes in the US
Research Article August 4 2025
Ivosidenib or venetoclax combined with hypomethylating agents in IDH1-mutated acute myeloid leukemia: a real-world study
Research Article August 4 2025
B-cell-Specific Wwox Deletion Promotes Plasmablastic Tumor Development and Pro-Inflammatory Signatures in Myeloma Model
Research Article August 4 2025
Orally Available Decitabine Prodrug OR-2100 induces Mitotic Perturbation for The Treatment Of Double-Hit Lymphoma
Research Article August 4 2025
Hypertension in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in ALPINE: A Secondary Analysis
Research Article August 4 2025
MNT: a new target for AML
Brief Report August 4 2025
Neutrophil-mediated trogocytosis as a new mechanism of action of daratumumab
Brief Report August 4 2025
A single nucleotide polymorphism in the TCL1A promoter is not protective in patients with germline RUNX1-FPD
Research Article August 4 2025
Bendamustine switches TNF receptor superfamily signal from a survival to a death signal in B-cell lymphomas
Brief Report August 4 2025
Loss of STAT3 in Acute Myeloid Leukemia Favors Tissue Infiltration Linked to CXCR4 Signaling
Research Article July 25 2025
Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1
Review Article July 25 2025
How to drug a leukemic stem cell: deciphering heterogeneity for better specificity
Brief Report July 25 2025
A Prospective Study of Prophylactic Dexamethasone with Glofitamab in Relapsed/Refractory Large B-cell Lymphoma
Brief Report July 25 2025
Eμ-TCL1 mice with conditional human BCL2 knock-in as novel B cell lymphoma model for studying venetoclax effects in vivo
Brief Report July 25 2025
SRSF2 Mutations in CCUS, MDS and AML: A Cross-Entity Study
Research Article July 25 2025
Targeting CDK9 inhibits the growth of KMT2A rearranged infant leukemia and demonstrates synergy with menin inhibition
Research Article July 25 2025
Shelter in place: Live CLL cells inside the bone marrow fibroblasts and its implication in residual disease persistence
Brief Report July 22 2025
Three-year follow-up of low-dose, early-start gilteritinib maintenance in posttransplant patients with R/R FLT3mut AML
Brief Report July 16 2025
IgA or IgM MGUS less than 1.0 g/dL is at Low Risk of Progression to Neoplasm
Brief Report June 30 2025
Posttranscriptional activity of eIF4E contributes to HoxA9-driven leukemogenesis
Research Article June 30 2025
Intensive Chemotherapy vs. Venetoclax/Hypomethylating Agents for Patients Aged 60-75 with Favorable, NPM1-mutated AML
Review Article June 19 2025
Current Landscape of Frontline and Relapsed Follicular Lymphoma Trials
Research Article June 9 2025
Correlates of Organ Damage in Advanced Systemic Mastocytosis Patients Enrolled in Clinical Trials of Avapritinib
Research Article June 3 2025
V-FAST: A phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML
Research Article June 3 2025
Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML
Research Article May 11 2025
A Comparative Assessment of Molecular-Based Prognostic Models in CMML
Research Article April 16 2025
Olfactory Receptors as Tumor Suppressors in Cutaneous T-Cell Lymphoma via p38γ Pathway Modulation

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals